SHARE
Vaccine Adjuvants Market

Vaccine Adjuvants - Global Market Outlook (2017-2026)

4.5 (46 reviews)
Published: January 2019 ID: SMRC17944
4.5 (46 reviews)
Published: January 2019 ID: SMRC17944

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Vaccine Adjuvants Market is accounted for $460.21 million in 2017 and is expected to reach $1,330.25 million by 2026 growing at a CAGR of 12.5% from 2017 to 2026. Some of the factors such as the high occurrence of zoonotic and infectious syndromes, growing geriatric population and rising usage of Adjuvants in Vaccine are fueling the market growth. However, factors such as cost of adjuvant development and side effects of adjuvants are hampering the market growth. The rising usage of synthetic vaccines and recombinant sub-unit are acting as an opportunity for the market growth in the coming years.

Adjuvants are fundamentally compounds that improve the body’s immunogenic reaction against antigens. As a result, these are majorly added to vaccines to increase their capability to influence long-term protection and safety against any kind of viruses. Currently, MF59 and aluminum salts are the only adjuvants which are viable for human usage. There have been a lot of developments done on the antigen discovery over the past decade which has enhanced the vaccine development process.

Amongst Route of Administration, Intramuscular Route segment is driven by owing to rapidly rising geriatric population and vaccines for enhanced immunization are propelling the growth of this segment. These include vaccines for HPV, influenza, meningitis, etc. By geography, North America region is dominated the market during the forecast period due to factors such as higher adoption, greater knowledge about regular vaccination and presence of major market players, coupled with higher healthcare expenditure.

Some of the key players in Vaccine Adjuvants market include Viscogel AB, Vaxliant, Vaxine Pty Ltd., Sigma Aldrich (Merck KGaA), Sergeant Adjuvants, OZ Biosciences, Novavax, Inc., Novartis/CSL, MVP Laboratories, Inc., Kineta, Inc., Invivogen, GSK, CureVac AG, CSL Limited, Avanti Polar Lipids, Aphios Corp., Agenus, Inc., Adjuvatis and Adjuvance Technologies, Inc.

Products Covered:
• Pathogen Components
• Particulate Adjuvants
• Combination Adjuvants
• Adjuvant Emulsions
• Saponin
• Other Types

Disease Types Covered:
• Cancer
• Infectious Diseases
• Other Disease Types

Types Covered:
• Virus-like Particles
• Tensoactive Adjuvants     
• Organic Adjuvants
• Mineral Salt based Adjuvants  
• Liposomes            
• Emulsions         
• Carbohydrates Adjuvants       
• Bacteria-derived Adjuvants
• Other Types

Mechanism of Actions Covered:
• Vehicle Adjuvants
• Carriers    
• Active Immunostimulants

Route of Administrations Covered:
• Subcutaneous Route
• Oral Route
• Intranasal Route
• Intramuscular Route
• Intradermal Route
• Other Route of Administrations

Applications Covered:
• Veterinary Vaccine Adjuvants
• Human Vaccine Adjuvants

End Users Covered:
• Research Institutes
• Pharmaceutical Companies
• Contract Manufacturing Organization
• Commercial
• Pediatric
• Adults
• Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Company Profiling
    o Comprehensive profiling of additional market players (up to 3)
    o SWOT Analysis of key players (up to 3)
Regional Segmentation
    o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
Competitive Benchmarking
    o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials